Galecto, Inc. (GLTO) SEC Filing 8-K Material Event for the period ending Thursday, February 3, 2022

Galecto, Inc.

CIK: 1800315 Ticker: GLTO

View differences made from one to another to evaluate Galecto, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Galecto, Inc..


Assess how Galecto, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Galecto, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Galecto, Inc. provided additional information to their SEC Filing as exhibits

Ticker: GLTO
CIK: 1800315
Form Type: 8-K Corporate News
Accession Number: 0001564590-22-004414
Submitted to the SEC: Wed Feb 09 2022 4:30:54 PM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Thursday, February 3, 2022
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: